Arkolith/Insider Trading/BMEA/Form 4

A2A Pharmaceuticals, Inc.

10% OwnerBiomea Fusion, Inc. (BMEA) · full profile →Form 4 · filed Apr 6, 2023
Net Buying
Open-Market Buys
$6.3M
Open-Market Sells
$0
Net Open-Market Flow
$6.3M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 31, 2023Buy(S)200K$31.25$6.3M4.1M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001859061-23-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML